← FDA Drug Approvals (Drugs@FDA)
ERYTHROMYCIN LACTOBIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2020-09-17
Drug application
- FDA Application #
ANDA211086- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYTHROMYCIN LACTOBIONATE
- Generic name
- Erythromycin Lactobionate
- Active ingredients
- ERYTHROMYCIN LACTOBIONATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- EXELA PHARMA
- First approval
- 2020-09-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown